🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to evaluate the safety, tolerability and imm...
Status
Unknown
Location
Al Kuwait Hospital (Al Baraha Hospital)
Start Date
2021-12-22
Trial ID
NCT05043311
This study is a randomized, double-blind, placebo-controlled Phase II clini...
Status
Completed
Location
Lianshui County Center for Disease Control and Prevention
Start Date
2023-01-05
Trial ID
NCT05652543
Treatments Being Tested
The objective of the study is to evaluate the immunogenicity and safety of ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-04-01
Trial ID
NCT05308602
Treatments Being Tested
The objective of this study is to evaluate the immunogenicity and safety of...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-04-25
Trial ID
NCT05239975
The objective of this study is to evaluate the effectiveness of SCTV01E in ...
Status
Unknown
Location
Guizhou center for disease control and prevention
Start Date
2022-12-26
Trial ID
NCT05308576
The objective of this study is to evaluate the immunogenicity and safety of...
Status
Unknown
Location
Multiple Locations
Start Date
2022-03-20
Trial ID
NCT05238441
The objective of this study is to evaluate the effectiveness of SCTV01E in ...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-25
Trial ID
NCT05683561
SCTV01C-02-1 is a randomized, double-blind, placebo controlled Phase Ⅰ/Ⅱ cl...
Status
Completed
Location
Anhui Provincial Hospital
Start Date
2021-12-01
Trial ID
NCT05148091
The objective of this study is to evaluate the safety, tolerability, and im...
Status
Unknown
Location
Al Kuwait Hospital (Al Baraha Hospital)
Start Date
2021-12-22
Trial ID
NCT05043285
The objective of this study is to evaluate the immunogenicity and safety of...
Status
Unknown
Location
Multiple Locations
Start Date
2022-03-20
Trial ID
NCT05238454
Treatments Being Tested